These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38669836)

  • 61. Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues.
    Myrick H; Malcolm R; Taylor B; LaRowe S
    Ann Clin Psychiatry; 2004; 16(2):101-9. PubMed ID: 15328903
    [TBL] [Abstract][Full Text] [Related]  

  • 62. EFNS guidelines on management of narcolepsy.
    Billiard M; Bassetti C; Dauvilliers Y; Dolenc-Groselj L; Lammers GJ; Mayer G; Pollmächer T; Reading P; Sonka K;
    Eur J Neurol; 2006 Oct; 13(10):1035-48. PubMed ID: 16987156
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Severe mania complicating treatment of narcolepsy with cataplexy.
    Crosby MI; Bradshaw DA; McLay RN
    J Clin Sleep Med; 2011 Apr; 7(2):214-6. PubMed ID: 21509339
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Status cataplecticus as initial presentation of late onset narcolepsy.
    Panda S
    J Clin Sleep Med; 2014 Feb; 10(2):207-9. PubMed ID: 24533005
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials.
    Kuan YC; Wu D; Huang KW; Chi NF; Hu CJ; Chung CC; Tam KW; Huang YH
    Clin Ther; 2016 Apr; 38(4):874-88. PubMed ID: 26923035
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Duration of activity and mode of action of modafinil: Studies on sleep and wakefulness in humans.
    Turner C; Belyavin AJ; Nicholson AN
    J Psychopharmacol; 2014 Jul; 28(7):643-54. PubMed ID: 24306135
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.
    Schwartz JR; Hirshkowitz M; Erman MK; Schmidt-Nowara W
    Chest; 2003 Dec; 124(6):2192-9. PubMed ID: 14665500
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modafinil Use in an Adolescent With Major Depressive Disorder.
    Özer Çakır E; Karakuş OB; Adak İ
    J Clin Psychopharmacol; 2024 Sep-Oct 01; 44(5):514-516. PubMed ID: 39008890
    [No Abstract]   [Full Text] [Related]  

  • 69. In-field assessment of sodium oxybate effect in pediatric type 1 narcolepsy: an actigraphic study.
    Filardi M; Pizza F; Antelmi E; Ferri R; Natale V; Plazzi G
    Sleep; 2018 Jun; 41(6):. PubMed ID: 29522206
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
    Talbot K; Stradling J; Crosby J; Hilton-Jones D
    Neuromuscul Disord; 2003 Jun; 13(5):357-64. PubMed ID: 12798791
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation.
    Brun J; Chamba G; Khalfallah Y; Girard P; Boissy I; Bastuji H; Sassolas G; Claustrat B
    J Sleep Res; 1998 Jun; 7(2):105-14. PubMed ID: 9682182
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of modafinil following acute CPAP withdrawal: a preliminary study.
    Williams SC; Rogers NL; Marshall NS; Leung S; Starmer GA; Grunstein RR
    Sleep Breath; 2008 Nov; 12(4):359-64. PubMed ID: 18311493
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy.
    Jasinski DR; Kovacević-Ristanović R
    Clin Neuropharmacol; 2000; 23(3):149-56. PubMed ID: 10895398
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study.
    Joo EY; Tae WS; Jung KY; Hong SB
    J Sleep Res; 2008 Mar; 17(1):82-8. PubMed ID: 18275558
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
    Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessment of brain activity during memory encoding in a narcolepsy patient on and off modafinil using normative fMRI data.
    Allen MD; Hedges DW; Farrer TJ; Larson MJ
    Neurocase; 2012 Feb; 18(1):13-25. PubMed ID: 21985031
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates.
    Willie JT; Renthal W; Chemelli RM; Miller MS; Scammell TE; Yanagisawa M; Sinton CM
    Neuroscience; 2005; 130(4):983-95. PubMed ID: 15652995
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients.
    Lin JS; Dauvilliers Y; Arnulf I; Bastuji H; Anaclet C; Parmentier R; Kocher L; Yanagisawa M; Lehert P; Ligneau X; Perrin D; Robert P; Roux M; Lecomte JM; Schwartz JC
    Neurobiol Dis; 2008 Apr; 30(1):74-83. PubMed ID: 18295497
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment.
    Weaver TE; Chasens ER; Arora S
    J Clin Sleep Med; 2009 Dec; 5(6):499-505. PubMed ID: 20465014
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modafinil: a second look. Confirmed efficacy in narcolepsy.
    Prescrire Int; 1999 Feb; 8(39):5-7. PubMed ID: 10557564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.